About the stock: Granules is a large-scale vertically integrated company that manufactures API, intermediates and finished dosages. It owns eight manufacturing facilities catering mainly for export markets (~94% of sales). In April 2025, it acquired Senn Chemicals AG, a Swiss CDMO specializing in peptide...